TXMD - TherapeuticsMD, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Cash flows from operating activities
Net Income
-169,739
-132,617
-76,925
-89,875
-85,077
Depreciation & amortization
391
294
213
132
62
Deferred income taxes
-
-
-
-
-
Stock based compensation
9,758
8,662
6,889
17,411
7,190
Change in working capital
-2,782
16,364
-6,337
665
-1,241
Accounts receivable
-13,103
-6,951
168
-3,976
-918
Inventory
-5,614
-1,782
-409
-386
492
Accounts Payable
8,072
18,646
-3,261
4,232
-3,201
Other working capital
-173,588
-128,134
-76,983
-70,384
-79,628
Other non-cash items
1,000
270
-
17,411
7,190
Net cash provided by operating activites
-150,891
-106,812
-76,156
-69,142
-79,044
Cash flows from investing activities
Investments in property, plant and equipment
-22,698
-21,322
-827
-1,241
-584
Acquisitions, net
-
-
-
-
-
Purchases of investments
-
-
-
-
-
Sales/Maturities of investments
-
-
-
-
-
Other investing activites
-184
-175
-
-14
0
Net cash used for investing activites
-22,882
-21,498
-827
-1,255
-584
Cash flows from financing activities
Debt repayment
-
-
-
-
-
Common stock issued
-
89,908
68,573
134,863
91,375
Common stock repurchased
-
-
-
-
-
Dividends Paid
-
-
-
-
-
Other financing activites
118,348
-3,787
-
0
0
Net cash used privided by (used for) financing activities
202,232
162,787
72,584
137,226
92,973
Net change in cash
28,459
34,477
-4,398
66,828
13,345
Cash at beginning of period
154,387
127,136
131,534
64,706
51,362
Cash at end of period
182,846
161,613
127,136
131,534
64,706
Free Cash Flow
Operating Cash Flow
-150,891
-106,812
-76,156
-69,142
-79,044
Capital Expenditure
-22,698
-21,322
-827
-1,241
-584
Free Cash Flow
-173,588
-128,134
-76,983
-70,384
-79,628